Ascribe PLC - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Ascribe PLC. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Ascribe PLC. The Group's principal activity is developing, supplying and supporting software solutions. The Group's operation focuses on providing software solutions supporting patient, clinical and business processes to the international healthcare market. The Group's operation relates to hospital and pharmacy systems, emergency department, retail pharmacy, mental health, primary and social care. The Group's software products ensures that the drug prescribed will not react with any patient allergies, with any medicine the patient is already taking, and furthermore checks that the drug dose is correct for the patient's height, weight and other related information. Product brands include Ascribe, E-MAT, ePEX, Exeter, Park ETP and Symphony. The Group operates predominantly in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report